Regulation of Sodium-Iodide-Symporter Gene Expression in Human Thyrocytes Measured by Real-Time Polymerase Chain Reaction

Summary

The sodium-iodide-symporter (NIS) plays a key role in iodination, the first step in the biosynthesis of the thyroid hormones, and is thought to be critically involved in several thyroid disorders associated with altered iodine up-take. To elucidate the pathogenic role of NIS in these diseases a sensitive technique is needed to measure human NIS gene expression.

We established a real time RT-PCR for accurate quantification of hNIS mRNA levels based on fluorescence-labelled hybridisation probes in the LightCycler system. Human NIS expression was investigated in primary cultures of human thyrocytes. After optimisation of PCR conditions less than 10 molecules hNIS were detected with high sensitivity, specificity and reproducibility. Under basal conditions NIS expression varied from 83 to 593 copies per 10⁶ GAPDH molecules. Stimulation of thyrocytes with TSH (0.1-10 U/ml) or forskolin (0.1-15 μM) results in a dose- and time-dependent up-regulation of NIS expression reaching a maximum at 10 mU/ml TSH (2211 ± 761 copies) or 10 μM forskolin (1663 ± 302 copies) after 24 h.

In conclusion, we here established a real-time RT-PCR combining the advantages of rapid thermocycling and online detection of NIS mRNA amplification. The sensitive quantification of human NIS mRNA expression offered by this novel technique may improve analysis of hNIS regulation and measurement of NIS mRNA expression in small biopsies.

Sodium-iodide-symporter - NIS - LightCyler - Quantitative RT-PCR - Thyroid

References

• 1 Ajjan R A, Kamaruddin N A, Crisp M, Watson P F, Ludgate M, Weetman A P. Regulation and tissue distribution of the human sodium/iodide symporter gene.  Clin Endocrinol. 1998a;  49 517-523
• 2 Ajjan R A, Watson P F, Findlay C, Metcalfe R A, Crisp M, Ludgate M, Weetman A P. The sodium/iodide symporter gene and its regulation by cytokines found in autoimmunity.  J Endocrinol. 1998b;  158 351-358
• 3 Arturi F, Russo D, Schlumberger M, Villard J A, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez H G, Filetti S. Iodine symporter gene expression in human thyroid tumors.  J Endocrinol Metab. 1998;  83 2493-2496
• 4 Aust G, Heuer M, Laue S, Lehmann I, Hofmann A, Heldin N E, Scherbaum W A. Expression of tumour necrosis factor-alpha (TNF-alpha) mRNA and protein in pathological thyroid tissue and carcinoma cell lines.  Clin Exp Immunol. 1996;  105 148-154
• 5 Bustin S A. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.  J Mol Endocrinol. 2000;  25 169-193
• 6 Carrasco N. Iodide transport in the thyroid gland.  Biochimi Biophys Acta. 1993;  1154 65-82
• 7 Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter.  Nature. 1996;  379 458-460
• 8 Dohan O, Baloch Z, Banrevi Z, Livolsi V, Carrasco N. Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases.  J Endocrinol Metab. 2001;  86 2697-2700
• 9 Kawaguchi A, Ikeda M, Endo T, Kogai T, Miyazaki A, Onaya T. Transforming growth factor-β1 suppresses thyrotropin-induced Na⁺/I^- symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells.  Thyroid. 1997;  7 789-794
• 10 Kogai T, Endo T, Saito T, Miyazaki A, Kawaguchi A, Onaya T. Regulation by thyroid stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.  Endocrinology. 1997;  138 2227-2232
• 11 Kreuzer K A, Lass U, Bohn A, Landt O, Schmidt C A. LightCycler technology for the quantitation of bcr/abl fusion transcripts.  Cancer Res. 1999;  59 3171-3174
• 12 Lazar V, Bidart J M, Caillou B, Mahe C, Lacroix L, Filetti S, Schlumberger M. Expression of the Na⁺/I^- symporter gene in human thyroid tumors: a comparison study with other thyroid specific genes.  J Endocrinol Metab. 1999;  84 3228-3234
• 13 Pekary A E, Hershman J M, Berg L. Tumor necrosis factor, ceramide, transforming growth factor-β1, and aging reduce Na⁺/I^- symporter messenger ribonucleic acid levels in FRTL-5 cells.  Endocrinology. 1998;  139 703-712
• 14 Pfaffl M. Development and validation of an externally standardised quantitative insulin-like growth factor-1 RT-PCR using LightCycler SYBR Green I technology.  Biochemica. 2000;  3 13-16
• 15 Saito T, Endo T, Kawaguchi A, Ikeda M, Katoh R, Kawaoi A, Muratmatsu A, Onaya T. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas.  J Clin Invest. 1998;  101 1296-1300
• 16 Schmutzler C. Regulation of the sodium/iodide symporter by retinoids - a review.  Exp Clin Endocrinol Diabetes. 2001;  109 41-44
• 17 Seissler J, Wagner S, Schott M, Feldkamp J, Lettmann M, Scherbaum W A, Morgenthaler N G. Detection of autoantibodies to the full length human Na⁺/I^- symporter expressed by in vitro transcription/translation: evidence for low frequency in patients with autoimmune thyroid disease.  J Endocrinol Metab. 2000a;  85 4630-4634
• 18 Seissler J, Nguyen T BT, Aust G, Steinbrenner H, Scherbaum W A. Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic β-cells.  Diabetes. 2000b;  49 1137-1141
• 19 Smanik P A, Liu Q, Furminger T L, Ryu K Y, Xing S, Mazzaferri E L, Jhiang S M. Cloning of the human sodium iodide symporter.  Biochem Biophys Res Comm. 1996;  226 339-345
• 20 Spitzweg C, Heufelder A E, Morris J C. Thyroid iodine transport.  Thyroid. 2000;  10 321-330